In this interview, recorded at TCT 2022 in Boston (US), just after the results of PREDICT-LAA were presented, Prof Ole De Backer (Rigshospitalet, Copenhagen University Hospital, DK), the lead investigator of the trial, explains the core objectives of PREDICT-LAA and the key results that him and his investigators observed during this randomised trial. Watch the interview to discover PREDICT-LAA's impact on the structural heart community.
PREDICT-LAA trial aims to study the effect of FEops HEARTguide™, a preoperative computer simulation planning based on CT imaging – on left atrial appendage (LAA) occlusion.
